Some seriously bad news for the Dodgers: Ken Rosenthal reports that the initial prognosis on Clayton Kershaw is that he will miss 4-6 weeks with his bad back. A final determination will be made after he gets a second medical consultation.
Kershaw exited Sunday’s start against the Braves with back tightness after just two innings of work. He was seen talking with trainers in the dugout after completing the top of the second inning and did not return to the mound for the third. Kershaw has a history of back problems. Last year he missed over two months with a herniated disc in his back.
Assuming the preliminary schedule holds, Kershaw would be on the shelf until late August at the earliest, but more likely early-to-mid September. The Dodgers currently hold a 10.5 game lead in the NL West so they can withstand his absence. But if they have any hopes of advancing in the playoffs, they’ll need a fully armed and operational Clayton Kershaw to do it.
Mets left-hander Jason Vargas has a non-displaced fracture of the hamate bone in his right hand, the team announced Sunday. Vargas sustained the injury after taking a comebacker off of his hand on Friday and is expected to consult with a hand specialist later today as the team settles on a course of action. Comments from GM Sandy Alderson indicate that surgery is a possibility, though the left-hander may also pitch through it for the time being.
Vargas, 35, signed a two-year, $16 million pact with the team last month. He completed a four-year run with the Royals in 2017, earning his first career All-Star nomination with an 18-11 record in 32 starts and producing a 4.16 ERA, 2.9 BB/9 and 6.7 SO/9 over 179 2/3 innings. Prior to the incident, the southpaw was expected to help fill out the back end of the Mets’ Opening Day rotation.
Kristie Ackert of the New York Daily News estimates that Vargas will likely miss the start of the season as he faces a two- to six-week recovery period. It’s a disappointing turn of events for a pitching staff that has been absolutely ravaged by injuries over the last couple of years.